Covered recipient · General Payments record
YOUNG S CHAE
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$1,747.94
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.94 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $269.22 | 11 |
| VIVUS LLC | $35.42 | 2 |
| Lilly USA, LLC | $22.01 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.97 | 1 |
| RedHill Biopharma Inc. | $14.49 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.95 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434326 | CMS |
| ABBVIE INC. | $124.83 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434328 | CMS |
| ABBVIE INC. | $16.68 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434330 | CMS |
| ABBVIE INC. | $17.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434332 | CMS |
| ABBVIE INC. | $18.99 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434334 | CMS |
| ABBVIE INC. | $18.97 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434336 | CMS |
| ABBVIE INC. | $9.30 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434338 | CMS |
| ABBVIE INC. | $12.64 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434340 | CMS |
| ABBVIE INC. | $5.03 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434342 | CMS |
| ABBVIE INC. | $14.42 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434344 | CMS |
| ABBVIE INC. | $13.41 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103434346 | CMS |
| Lilly USA, LLC | $22.01 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135519973 | CMS |
| RedHill Biopharma Inc. | $14.49 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095478445 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.83 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153667302 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.97 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137505891 | CMS |
| VIVUS LLC | $17.00 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415014 | CMS |
| VIVUS LLC | $18.42 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415016 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.